Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens
Pediatrics - United States
doi 10.1542/peds.104.3.e32
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 1999
Authors
Publisher
American Academy of Pediatrics (AAP)